Coherus BioSciences, Inc.·4

Jan 6, 6:17 PM ET

Lanfear Dennis M 4

4 · Coherus BioSciences, Inc. · Filed Jan 6, 2023

Insider Transaction Report

Form 4
Period: 2023-01-04
Lanfear Dennis M
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2023-01-04$9.87/sh10,905$107,632568,603 total
  • Award

    Stock Option (Right to Buy)

    2023-01-05+402,500402,500 total
    Exercise: $10.37Exp: 2033-01-05Common Stock (402,500 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    432,684
  • Common Stock

    (indirect: By LLC)
    86,965
Footnotes (4)
  • [F1]Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
  • [F2]These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
  • [F3]These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
  • [F4]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4